Modified Starch Market Dynamics: Drivers, Restraints, and Emerging Opportunities

The global modified starch market is valued at USD 14.92 billion in 2025 and is projected to reach USD 17.30 billion by 2030, growing at a CAGR of 3.0%. Market expansion is driven by the rising focus on product stability, texture improvement, and clean-label functionality across processed and convenience food categories. As consumers increasingly prefer healthier, high-quality, and easy-to-use food products, demand for transparent and natural ingredient solutions has surged—strengthening the adoption of modified starches in multiple applications.

A growing shift toward functional, science-backed ingredients that enhance viscosity, binding, freeze–thaw stability, and overall performance is further accelerating market growth.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=511

Dominance of Physically Modified Starch

The physically modified starch segment is expected to hold the largest market share during the forecast period. This category has gained strong traction because it supports the global trend toward clean-label, natural, and minimally processed ingredients while still offering robust functional benefits.

Produced through non-chemical processes such as heat–moisture treatment, pregelatinization, annealing, extrusion, and spray drying, physically modified starch enhances key properties like solubility, viscosity, water absorption, and freeze–thaw stability—without the use of chemical agents. This enables simpler ingredient labeling, which appeals to health-conscious consumers and aligns with stringent regulatory standards in regions such as Europe and parts of Asia.

Moreover, physically modified starches offer cost-efficient production, easy scale-up, and versatile formulation capabilities across bakery, dairy, snacks, instant foods, gluten-free items, pharmaceuticals, and industrial applications. Their reliability, consistency, and regulatory compliance continue to position them as the preferred choice across both food and non-food sectors.

Dry Form Leads Market Adoption

The dry form of modified starch is projected to account for a significant market share due to its superior stability, long shelf life, and convenient storage and transportation. Its powdered form enables accurate dosing, simple handling, and seamless blending across food and industrial processes.

Widely utilized in bakery mixes, instant foods, snacks, adhesives, paper applications, and pharmaceuticals, dry modified starch is favored for its compatibility with high-temperature and high-shear environments. Reduced logistics costs, minimal spoilage risks, and broad functional versatility continue to make dry starch the most preferred format globally.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=511

Asia Pacific: The Fastest-Growing Regional Market

Asia Pacific is poised to remain the fastest-growing region in the modified starch market, supported by a strong agricultural foundation, rapid industrialization, and a booming food processing sector. Countries such as China, India, Thailand, Indonesia, and Vietnam benefit from abundant raw materials—including cassava, corn, and potatoes—providing the region with a significant production and cost advantage.

Urbanization, evolving lifestyles, and increasing consumption of processed and convenience foods continue to drive modified starch demand in bakery, dairy, snacks, and ready-to-eat products. Additionally, rising applications in pharmaceuticals, textiles, adhesives, and paper manufacturing are accelerating regional growth. Government initiatives promoting agri-processing and bio-based industries, along with strategic investments by global and local manufacturers in R&D, new facilities, and partnerships, further strengthen the region’s market dominance.

Leading Modified Starch Companies:

The report profiles key players such as ADM (US), Cargill (US), Ingredion (US), Tate & Lyle (UK), Roquette Frères (France), Avebe U.A. (Netherlands), Grain Processing Corporation (US), Emsland (Germany), AGRANA (Austria), SMS Corporation (Thailand), Global Bio-Chem Technology Group (Hong Kong), SPAC Starch (India), Qingdao CBH Company (China), Tereos (France), and KMC (Denmark).

Algae Products Market Analysis: Key Drivers, Restraints, and Growth Prospects

The algae products market is projected to grow from USD 5.87 billion in 2025 to USD 8.07 billion by 2030, registering a CAGR of 6.6% during the forecast period. Steady growth in the market is driven primarily by rising consumer awareness of the health benefits associated with algae. Increasing demand for natural, nutritious, and plant-based food options—alongside preferences for better taste and texture—continues to expand opportunities for algae-derived products. Algae provide valuable nutrients such as omega-3 fatty acids (including DHA) and algal proteins, making them especially attractive to vegetarian and vegan consumers. However, high production costs remain a key challenge, particularly for small-scale companies striving to meet quality standards, which may constrain overall market expansion.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=250538721

Red algae segment expected to grow significantly

Among algae product sources, red algae are poised for notable growth during the forecast period. Species such as Porphyra (47% protein by dry mass) and Palmaria palmata (35% protein by dry mass) are widely consumed in Asian and Western markets due to their high protein content and appealing flavor. Red algae also play a vital ecological role, contributing 40% to 60% of global oxygen production, supporting both terrestrial and aquatic ecosystems. Their commercial value is particularly significant in regions like Japan and the North Atlantic, where they are regarded as essential food sources.

Animal feed to hold a substantial market share

The use of algae in animal feed is rapidly increasing. Algae-based aquafeed has demonstrated both nutritional and economic benefits. Research published in the Journal of the Institute of Food Technology indicates that incorporating specific microalgae species into fish diets can reduce feed costs by up to 50% while enhancing nutrient density. Owing to their rich profiles—containing essential fatty acids, amino acids, carbohydrates, carotenoids, and vitamins—both microalgae and macroalgae have become sustainable and effective nutritional sources for livestock, poultry, and aquaculture.

Asia Pacific to record the highest CAGR

The Asia Pacific region is anticipated to witness the fastest growth in the algae products market during the forecast period. Major contributors include China, Japan, India, and Australia & New Zealand, all of which possess expansive coastlines ideal for cultivating marine and freshwater algae. The region’s tropical climate supports the world’s greatest diversity of algae species, driving production and market adoption.

Rising population levels across Asia Pacific are boosting demand across the food & beverage, pharmaceutical, and personal care sectors, further propelling market growth. Edible seaweeds—such as Kombu (Laminaria japonica), Nori (Porphyra sp.), and Wakame (Undaria pinnatifida)—are widely used in traditional Chinese and Japanese cuisines, including soups, salads, cooked dishes, and sushi.

Beyond food applications, seaweeds play a crucial role in producing hydrocolloids and phycocolloids and are extensively utilized in pharmaceuticals, cosmetics, agriculture, biofuels, and animal feed additives. Given their abundant primary and secondary metabolites, algae-derived products have strong potential in the food and nutraceutical industries, offering substantial growth prospects for the market across the region.

Leading Algae Products Companies:

The report profiles key players such as DSM-Firmenich (Netherlands), BASF (Germany), and Cyanotech Corporation (US), Cargill, Incorporated (US), CP Kelco U.S., Inc. (Tate & Lyle) (US), Corbion (Netherlands), E.I.D.-Parry (India), Kerry Group plc (Ireland), AlgaTech Ltd. (Israel), Algenol Biotech (US), Cellana Inc. (US), Fenchem (China), Fuji Chemical Industries Co., Ltd. (AstaReal Co., Ltd.) (Japan), Algea (Norway), KD Pharma Group SA (Switzerland), and others.

Global Agriculture Biotechnology Market Size, Share & Industry Forecast Report

The global agriculture biotechnology market is on a strong upward trajectory, projected to expand from USD 92.19 billion in 2025 to USD 144.25 billion by 2030, reflecting an impressive CAGR of 9.4%. This surge comes at a critical time as the world races to secure sustainable food systems for a population expected to reach nearly 10 billion by 2050. With mounting pressures on land, water, and ecosystems, biotechnology has emerged as a transformative tool in building climate-resilient, resource-efficient agricultural systems.

From genetic engineering to microbial innovations and animal biotechnology, the field is reshaping farms and food supply chains worldwide. Modern technologies—such as CRISPR gene editing, molecular diagnostics, fermentation-based solutions, and microbial biofertilizers—are enabling more precise, eco-friendly crop and livestock management. Farmers across major markets are increasingly adopting GM crops, biological pest control, microbe-based soil enhancers, and AI-integrated biotech tools to boost resilience and productivity while cutting chemical dependence.

Download PDF Brochure: 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=102440075

Plant & Microbial Biotechnology: Powering the Largest Market Share

During the forecast period, plant biotechnology and microbial biotechnology are set to account for a major share of the agriculture biotechnology landscape.

Plant Biotechnology

Plant biotechnology remains the largest segment due to the global adoption of genetically modified (GM) crops that offer:

• Higher yields
• Pest and disease resistance
• Improved tolerance to drought and heat

 

Growing acceptance of CRISPR-edited crops and biofortified varieties—particularly in emerging economies—is further accelerating market growth.

Microbial Biotechnology

Microbial biotechnology is expanding rapidly as farmers and governments seek sustainable alternatives to chemical inputs. Rising demand for:

• Biofertilizers
• Biocontrol agents
• Microbial biostimulants

 

is driving innovation and adoption. Supported by global soil restoration initiatives and emission-reduction goals, microbial solutions are reshaping nutrient and pest management. Together, plant and microbial biotechnology will remain the backbone of global agri-biotech growth through 2030.

 

Animal Biotechnology: Fastest-Growing Segment

The animal biotechnology segment is projected to record the fastest CAGR during the forecast period. Rising global consumption of meat, dairy, and poultry is pushing producers to adopt advanced biotechnologies such as:

• Genetic engineering for enhanced traits
• Next-generation vaccines
• Reproductive technologies
• Enzyme-based feed additives

 

These innovations boost disease resistance, feed efficiency, and animal welfare while reducing environmental footprints.

With zoonotic diseases on the rise and stricter regulations surrounding antibiotic use, biotechnology-based animal health solutions are gaining momentum across North America, Europe, and Asia Pacific. Industry leaders like Zoetis, Elanco, and Boehringer Ingelheim continue to invest heavily in molecular diagnostics and advanced vaccines, strengthening the segment’s growth trajectory.

Request Sample Pages: 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=102440075

North America: The Global Hub for Agricultural Biotechnology

North America is expected to maintain its dominant position in the agriculture biotechnology market through 2030. Several factors contribute to the region’s leadership:

• Strong R&D infrastructure
• Supportive regulatory bodies (USDA, EPA, FDA)
• Broad adoption of GM crops and biological inputs
• High investment in AI-driven and precision agriculture technologies

 

The U.S. remains the powerhouse of innovation, housing major players like Bayer Crop Science, Corteva Agriscience, Zoetis, and Novonesis. A robust ecosystem of research institutions, biotech companies, and government initiatives continues to accelerate breakthroughs in plant genetics, animal health, and microbial technologies.

With increasing emphasis on climate-resilient farming and sustainable food systems, North America is poised to remain at the forefront of global agricultural biotechnology innovation and commercialization.

 

Leading Agriculture Biotechnology Companies:

The report highlights prominent players shaping the agriculture biotechnology market, including:

• Bayer Crop Science
• Corteva Agriscience
• BASF SE
• Syngenta AG
• Zoetis Inc.
• Elanco Animal Health
• Novonesis (Novozymes + Chr. Hansen)
• Lallemand Plant Care

 

These companies continue to innovate across plant genetics, microbial solutions, animal vaccines, enzymes, and sustainable input technologies.

Controlled-release Fertilizers Market Outlook 2025–2030: Drivers, Challenges, and Future Prospects

The controlled-release fertilizers market is on a strong growth trajectory, projected to reach USD 3.41 billion by 2030 from USD 2.54 billion in 2025, registering a CAGR of 6.1% during the forecast period (2025–2030).

As global agriculture shifts toward sustainability and efficiency, the demand for CRFs is increasing rapidly. These fertilizers are engineered to release nutrients gradually, ensuring optimal plant uptake while minimizing environmental losses. The market growth is largely fueled by the rising need for higher crop yields, improved nutrient use efficiency, and reduced environmental impact.

Driving Forces Behind Market Growth

Farmers worldwide are adopting controlled-release fertilizers to achieve consistent nutrient availability, reduce application frequency, and enhance soil health. Environmental concerns—such as soil degradation, water pollution, and greenhouse gas emissions from conventional fertilizers—are prompting a transition to CRFs that promote sustainable nutrient management.

Technological advancements, including polymer-coated and biodegradable formulations, have improved the efficiency and adaptability of CRFs across different crops and climatic conditions. Moreover, supportive government policies, precision agriculture adoption, and long-term cost benefits are encouraging broader implementation among modern farmers.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=136099624

By Type: Nitrogen Stabilizers Lead the Market

The nitrogen stabilizers segment commands a significant share of the global CRF market due to its essential role in improving nitrogen utilization and minimizing environmental losses. These stabilizers—comprising urease and nitrification inhibitors—slow down nitrogen conversion in the soil, enabling crops to absorb nutrients efficiently over an extended period.

By reducing volatilization and leaching, nitrogen stabilizers help maintain soil fertility, boost yields, and lower fertilizer application frequency—especially valuable for large-scale and high-value crops. With mounting regulatory pressure to curb nitrogen runoff and growing awareness of sustainable farming, nitrogen-stabilized CRFs have become a cornerstone of eco-friendly agriculture.

Leading companies such as ICL, Nutrien, SQM, and Yara are integrating nitrogen stabilizers into their product portfolios to meet the dual goals of productivity and environmental stewardship.

By Function: Time-Release Systems Dominate

Time-release systems represent the largest segment of the controlled-release fertilizers market, credited for their ability to deliver nutrients in sync with crop growth cycles. Utilizing polymer-coated or matrix-based formulations, these fertilizers ensure steady nutrient availability, reducing losses caused by leaching or volatilization.

Their adaptability across a wide range of crops—including cereals, fruits, vegetables, and plantations—has driven widespread adoption. Farmers appreciate the convenience, reduced labor needs, and cost savings these systems offer, particularly in large-scale farming operations.

In addition, the ongoing development of biodegradable coatings and multi-nutrient formulations further enhances their appeal, reinforcing their pivotal role in sustainable and precision agriculture.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=136099624

By Region: North America Leads the Global Market

North America holds the largest share of the global CRFs market, supported by its advanced agricultural infrastructure, technological adoption, and commitment to sustainable practices. Farmers across the U.S. and Canada increasingly prioritize nutrient management strategies that maximize yields while minimizing ecological footprints.

The strong presence of key industry players—such as Yara, Nutrien, ICL, SQM, and Mosaic—combined with robust manufacturing and distribution networks, continues to strengthen regional market growth.

Government initiatives promoting precision farming and environmentally responsible fertilizer use have accelerated CRF adoption. Furthermore, R&D investments and innovations in coating technologies have expanded product versatility for diverse crops and soil types.

North America’s leadership in data-driven nutrient management and large-scale mechanized farming ensures efficient CRF use, delivering both agronomic and economic advantages.

Leading Controlled-release Fertilizers Companies:

Prominent companies driving innovation and competition in the controlled-release fertilizers market include:

Yara (Norway), Nutrien Ltd. (Canada), Mosaic (US), ICL (Israel), Nufarm (Australia), Kingenta (China), ScottsMiracle-Gro (US), Koch Industries (US), Helena Chemicals (US), SQM (Chile), Haifa Negev Technologies Ltd. (Israel), JCAM AGRI Co., Ltd. (Japan), COMPO EXPERT (Germany), The Andersons Inc. (US), and Van Iperen International (Netherlands).

Gummy Supplements Market Trends: Innovation, Flavor, and Formulation Strategies

The gummy supplements market is projected to reach USD 47.79 billion by 2030 from USD 24.39 billion in 2025, at a CAGR of 14.4%. The gummy supplements market is primarily driven by shifting consumer preferences toward health and wellness, with an increasing demand for convenient, tasty, and easy-to-consume dietary supplements. In North America, where health awareness is particularly high, consumers favor gummy supplements over traditional pills and capsules due to their enjoyable taste and user-friendly form. This market growth is further propelled by innovations in product formulations, including the introduction of natural, vegan, and plant-based ingredients, which align with contemporary consumer values. Additionally, the diverse product offerings target multiple age groups and address various health concerns, including immunity, bone health, and digestive support, thereby broadening the market appeal.

The expansion of e-commerce and pharmacy distribution channels enhances accessibility, while strategic marketing and personalized wellness trends contribute to sustained consumer engagement. Regulatory compliance, ensuring product safety and quality, also boosts market confidence. The interplay of convenience, innovation, and evolving lifestyle preferences constitutes the key drivers behind the robust growth of the gummy supplements market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=39376426

Vitamins & minerals segment is projected to hold the largest share during the forecast period

The vitamin gummies hold the largest share in the gummy supplements market driven by the evolving consumer lifestyles and health priorities. Consumers are increasingly seeking convenient and enjoyable ways to meet their daily nutritional needs, and vitamin gummies offer a tastier, more palatable alternative to traditional pills and capsules. The appeal of these products is further enhanced by the growing demand for formulations that incorporate clean-label, sugar-free, vegan, and plant-based ingredients, reflecting broader trends toward natural and transparent wellness options.

The ability of vitamin gummies to combine multiple essential nutrients in a single, flavorful serving caters to consumers’ preferences for simplified health routines that support immunity, energy, and overall well-being. The expansion of accessible distribution channels, including e-commerce and retail pharmacies, plays a pivotal role in increasing consumer reach and adoption. These factors boost the vitamin gummies segment’s position as the market leader, making it the preferred choice for consumers across diverse age groups and geographies who seek convenient and trustworthy nutritional supplementation.

Adult segment is projected to hold the largest share during the forecast period

The adult segment commands the largest share of the gummy supplements market, driven by lifestyle factors and health awareness. Adults, particularly those aged 18–60, seek convenient and flavorful alternatives to traditional supplement formats that fit seamlessly into busy routines. The appeal of gummy supplements lies in their ability to mask the unpleasant taste and texture of conventional pills, combating “pill fatigue” commonly experienced by this demographic. Moreover, adults undergo various physical and metabolic changes across their life stages that intensify the need for targeted nutritional support, such as vitamins for immunity, bone health, and energy.

This demand is supported by the widespread health consciousness and a proactive approach to preventive care, with many adults actively incorporating gummies into their daily wellness regimens. Furthermore, the availability of adult-focused formulations and strategic distribution through pharmacies, supermarkets, and online platforms enhances accessibility, fostering sustained growth and dominance of this segment in the gummy supplement market.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=39376426

North America is expected to hold the largest market during the forecast period, driven by the increasing demand for preventive healthcare

The North American gummy supplements market stands as the largest regional segment globally, driven by a combination of rising health consciousness, increasing demand for convenient supplement formats, and a growing aging population focused on preventive healthcare. Consumers in this region prefer gummy supplements over traditional pills due to their pleasant taste, ease of consumption, and alignment with modern lifestyles demanding simplicity and enjoyment in wellness routines. Innovation plays a critical role, with manufacturers introducing sugar-free, high-absorption, and multifunctional gummy products tailored to support immunity, bone health, digestive wellness, and energy.

The expanding distribution channels, including pharmacies, supermarkets, and e-commerce platforms, facilitate widespread accessibility, while regulatory support for product safety and quality bolsters consumer trust. Additionally, sustainability trends in packaging and clean-label formulations resonate with the North American consumers, underpinning the region’s dominant market position and fueling robust growth prospects.

The report profiles key players such as Church & Dwight Co., Inc. (US), H&H Group (Hongkong), Amway (US), The Clorox Company (US), Bayer AG (Germany), Haleon Group of Companies (UK), Nestle (Switzerland), Unilever (UK), Otsuka Pharmaceutical Co., Ltd. (Japan), PharmaCare Laboratories Australia (Australia), and Swanson (US).

Omega-3 Market: Innovations Shaping Consumer Preferences

The omega-3 market is estimated to be USD 4,362.2 million in 2025 and is projected to reach USD 7,756.4 million by 2030, at a CAGR of 12.2% from 2025 to 2030. Demand for omega-3 is projected to grow significantly as consumers become more aware of its role in supporting cardiovascular, cognitive, eye, and joint health. Unlike several other nutrients, omega-3 fatty acids, such as EPA and DHA, cannot be synthesized efficiently by the human body, resulting in increased reliance on dietary supplements, fortified foods, and pharmaceutical-grade formulations. Omega-3 oils are highly versatile and can be incorporated into capsules, powders, beverages, and functional foods while maintaining stability and efficacy. Fish oil, krill oil, and algal-based omega-3 are the most preferred sources, backed by scientific validation of their safety and effectiveness. The growing popularity among health-conscious consumers, coupled with increasing demand for clean-label and sustainable products, is expected to further strengthen the outlook for the omega-3 market in the coming years.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=227

By type, DHA segment to exhibit fastest growth rate during forecast period.

Docosahexaenoic acid (DHA), a polyunsaturated omega-3 fatty acid (PUFA), is widely distributed throughout the body and has emerged as the leading type segment in the omega-3 market. It serves as a significant structural fat present in both the brain and eye, constituting as much as 97% of the total omega-3 fats in the brain and up to 93% in the retina. The main sources of DHA are fish, fish oils, dairy products, and specialty eggs, with marine sources such as salmon and tuna being particularly rich. Farmed salmon contains about 1.24 g of DHA, and wild salmon about 1.22 g of DHA.

Additionally, DHA is a crucial component of cardiac tissue and is also commonly referred to as 22:6(n-3). Direct consumption of DHA is necessary to effectively increase fatty acid levels in the body, and optimal intake is crucial for both infant brain development and normal adult brain function. Epidemiological research further associates healthy DHA intake with a reduced risk of Alzheimer’s disease, as DHA improves communication between nerve cells and membranes by enhancing fluidity. Its critical role in visual and neurological development in infants, coupled with widespread applications in infant nutrition, dietary supplements, and functional foods, has solidified DHA as the dominating segment within the omega-3 market. The growing demand from both developed and emerging economies ensures that DHA continues to hold a substantial market share compared to other omega-3 types, such as EPA and ALA.

By application, infant formulas segment to record highest CAGR during forecast period.

The infant formulas segment is anticipated to grow at a significant rate in the omega-3 market due to the rising recognition of DHA’s crucial role in infant brain and eye development. DHA, often referred to as the “brain-building” omega-3, is recommended by leading health authorities such as the World Health Organization (WHO) and the European Food Safety Authority (EFSA) for inclusion in infant nutrition. With an increasing number of working mothers and a higher reliance on formula feeding, demand for fortified infant formulas containing DHA and EPA has surged worldwide. Manufacturers are consistently innovating by introducing premium formulas that mimic the fatty acid composition of human breast milk, further boosting adoption. Regulatory mandates in many regions, such as the EU’s requirement since 2020 for DHA inclusion in all infant formula and follow-on formula products, have led to the European Union (EU) implementing new regulations, effective February 22, 2021, regarding the recommended DHA supplementation in healthy diets. These regulations mandate that all infant formula and follow-on formula available for purchase within the EU must contain a minimum of 20 mg/100 kcal (or 4.8 mg/100 kJ) and a maximum of 50 mg/100 kcal (or 128 mg/100 kJ) of DHA, which is accelerating market growth. In addition, growing consumer preference for organic and clean-label formulas, along with strong demand in emerging economies driven by rising birth rates and improved purchasing power, is expected to fuel the segment's expansion during the forecast period.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=227

Europe to account for significant share in global omega-3 market.

Europe is expected to hold a significant share of the omega-3 market, driven by a robust regulatory framework, high consumer awareness, and a growing preference for preventive healthcare. Additionally, European consumers show a higher inclination toward premium dietary supplements and clean-label products, fostering demand for sustainable fish oil and plant/algal-based omega-3 alternatives. The presence of major global players, continuous research and development initiatives, and widespread adoption of fortified foods and beverages further strengthen Europe’s dominance. Moreover, increasing vegetarian and flexitarian populations in countries such as Germany, the UK, and France are accelerating the demand for algal-derived omega-3, ensuring steady market growth across the region. According to the European Food Safety Authority (EFSA), micronutrients present in omega-3s even benefit eye and brain health, which has led to heavy focus and a surge in consumption among Europeans. Companies such as Pelagia AS (Norway), Corbion (Netherlands), and dsm-firmenich (Netherlands) are the key players that are highly focused on catering to the demand for omega-3-based products in the European region. In 2023, several recent advancements were observed in the omega-3 market within the European region. Corbion (Netherlands) launched a new product, AlgaVia, whereas Pelagia AS (Norway) invested in its production facility to increase the output of the omega-3 concentrates.

The European Society of Cardiology (ESC) has had a significant impact on the omega-3 market in the European region, as its studies emphasize that omega-3 consumption helps decrease the risk of cardiovascular diseases. European omega-3 manufacturers are investing in omega-3 applications, such as dietary supplements, functional food & beverages, and pharmaceuticals. BASF SE (Germany) offers microencapsulated omega-3 powder with more shelf life to cater to the European demand. Furthermore, the rise in consumer awareness has prompted manufacturers to follow and adhere to European regulations, which is projected to drive growth in Europe.

Leading Omega-3 Manufacturers:

The report profiles key players such as BASF SE (Germany), Cargill, Incorporated (US), dsm-firmenich (Netherlands), ADM (US), Kerry Group plc (Ireland), Aker BioMarine (Norway), Croda International plc (UK), Corbion (Netherlands), Pelagia AS (Norway), KD Pharma Group SA (Switzerland), GC Rieber (Norway), Cooke Aquaculture Inc. (Canada), GOLDEN OMEGA (Chile), Polaris (France), Btsa (Spain), KinOmega Biopharm Inc. (China), Rimfrost AS (Norway), Mara Renewables (Canada), Cellana Inc. (US), AlgaeCytes Limited (UK), and others.

Food Enzymes Market Size, Share, and Competitive Landscape - 2030

The food enzymes market is estimated to be USD 2.98 billion in 2025 and is projected to reach USD 4.20 billion by 2030, at a CAGR of 7.2% from 2025 to 2030. The food enzymes market is witnessing robust growth as food and beverage manufacturers increasingly adopt enzyme-based solutions to improve processing efficiency, enhance product quality, and meet the evolving demands of health-conscious consumers. With applications ranging from dairy, bakery, and beverages to convenience foods and functional nutrition, food enzymes play a vital role in enhancing flavor, texture, shelf life, and digestibility. This surge in demand is being further fueled by advancements in biotechnology, clean-label trends, and regulatory support for sustainable and innovative food production processes, positioning the food enzymes market as a key driver in the future of food innovation.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=800

By source, microorganisms segment accounts for largest market share

Microorganisms represent the dominant segment in the global food enzymes market, driven by their efficiency, cost-effectiveness, and scalability in industrial applications. Enzymes derived from microbial sources such as bacteria, fungi, and yeasts are widely preferred due to their consistent performance, ease of production through fermentation, and adaptability across diverse food processing functions. Compared to plant or animal-derived enzymes, microbial enzymes offer more stability under varying temperature and pH conditions, making them suitable for high-demand processes in the bakery, dairy, beverages, and meat industries. Advances in biotechnology and genetic engineering have further enhanced the functionality of microbial enzymes, enabling tailored solutions that improve food quality, extend shelf life, and support clean-label product trends. Additionally, the growing shift toward sustainable and plant-based diets has amplified demand for microbial enzymes, as they align with consumer expectations for natural, non-animal-based ingredients. With continuous R&D investments and regulatory approvals supporting novel enzyme applications, microorganisms are expected to retain their leading position, underpinning growth and innovation in the food enzymes sector.

By type, lipases segment accounts for significant market share

Lipase enzymes hold a significant position within the food enzymes market, owing to their vital role in catalyzing the hydrolysis of fats, thereby improving the flavor, texture, and nutritional profile of various food products, including dairy, baked goods, and edible oils. Their capacity to effectively convert triglycerides into valuable components such as fatty acids and glycerol also supports broader applications in industrial biotechnology, particularly in the development of sustainable and environmentally responsible solutions. On September 16, 2024, Biocatalysts Ltd. introduced Lipomod 70MDP, a next-generation lipase specifically designed for the efficient hydrolysis of plant-based oils. This cutting-edge enzyme is engineered to enhance yields and process efficiency in the oleochemical industry, offering a viable alternative to conventional chemical-based methods. The launch of Lipomod 70MDP highlights Biocatalysts' ongoing commitment to sustainable innovation and operational excellence. As enzymatic technologies continue to gain traction across food and industrial domains, lipase remains a key driver of growth, with products like Lipomod 70MDP reinforcing its strategic importance and future potential in the global food enzymes landscape.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=800

Based on region, North America accounts for significant market share

North America holds a significant share in the food enzymes market, driven by the region’s strong bakery, dairy, and beverage industries, along with rising consumer demand for clean-label and longer-lasting products. This growth is supported by continuous innovation and strategic collaborations. For instance, on August 13, 2025, IFF launched POWERFRESH ACE 2000, a next-generation fresh-keeping enzyme tailored to US industrial bakeries. The enzyme improves bread softness and resilience for up to 34 days, addressing consumer expectations for extended freshness while enhancing production efficiency. Similarly, on September 15, 2025, Brenntag Specialties expanded its exclusive partnership with Lallemand Bio-Ingredients to distribute the Nutrilife baking enzyme range in North America, building on their existing European collaboration. This partnership aims to bring clean-label, high-performance enzyme solutions to the US. and Canadian markets, backed by Brenntag’s distribution strength and Lallemand’s fermentation expertise. These strategic initiatives reflect North America’s central role in the global food enzymes market, where innovation, consumer trends, and industrial efficiency converge to drive sustained market leadership and long-term growth opportunities.

The report profiles key players such as International Flavors & Fragrances Inc. (US), dsm-firmenich (Switzerland), Kerry Group plc (Ireland), Advanced Enzyme Technologies (India), Aumgene Biosciences (India), Amano Enzyme Inc. (Japan), Associated British Foods plc (England), and Novonesis Group (Denmark).